Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Three payment streams

<< Previous

Bullboard Posts

Next >>

Comment by jimmyhorizonon Aug 25, 2022 10:24am

165 Views

Post# 34919640

RE:RE:Three payment streams

He prepares us for the upfront to be below all expectations

He prepares us for the next fairytale

They want to maintain the price with communication. Because there is not and will not be anything else

It would be a miracle if a dozen people and a few molecules were to be worth hundreds of millions

It is not a scandal that they do not create a miracle. But they pretend they do, and that is a problem.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec